ORANGE, Conn., Feb. 10 /PRNewswire/ -- SurgiQuest, Inc. AirSeal Dynamic Pressure System(TM) was granted FDA 510(k) approval for smoke evacuation. The AirSeal DPS(TM) continuously re-circulates and filters CO2 used to insufflate the abdomen during laparoscopic surgical procedures.
Surgeons routinely have to interrupt laparoscopic surgical procedures due to impaired visualization caused by electrocautery smoke and plume within the operative environment. This impairment restricts access until the smoke is cleared. Often, the smoke is cleared by venting into the operating room in order to regain visualization/access. Continuous evacuation and filtering of smoke, is an integral function of the AirSeal DPS(TM) thereby creating a safer and more efficient working environment for the surgeon, patient and entire operating room staff.
"Our mission has been to improve access and visualization during laparoscopic procedures. One of the key features of the AirSeal DPS(TM) technology is the ability to automatically remove smoke during laparoscopic procedures providing the surgeon unencumbered access while improving visualization," said Kurt Azarbarzin, Founder and CEO of SurgiQuest.
About the AirSeal DPS(TM) access system:
The AirSeal Dynamic Pressure System(TM) provides unprecedented access by eliminating mechanical valves from the cannula and facilitating the introduction of multiple laparoscopic instruments through a single AirSeal(TM) cannula. Additionally; the AirSeal DPS(TM) system provides a proprietary clinical advantage through its ability to simultaneously monitor the insufflator to maintain (pneumoperitoneum) pressure inside the abdomen. This unprecedented, unencumbered approach to MIS is enabling both new procedure development and new instrument platforms geared toward enhancing clinical outcomes.
SurgiQuest, Inc. is a private venture-backed company, founded in May 2006. It develops, manufactures, and markets access technology for minimally invasive surgery.